Home
Orbimed Advisors reported a 6.2% stake in NeuroPace NPCE · 2,096,527 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.2%
- Last report
- 8% · filed 25/08/14
- Shares held
- 2,096,527 sh
- Class
- Common Stock, par value $0.001 per share
- Stock
- NeuroPace NPCE
- Holder
- Orbimed Advisors
- Event date
- 26/03/31
- Filed
- 26/05/15
6.2% stake · −1.8pp from the last report
- Stake
- 6.2%
- Last report
- 8%
- Since last report
- −1.8pp
NeuroPace trades, last 26 weeks
What else happened in NeuroPace around then
Filed or reported within 30 days of the trade day · 03/01~04/30Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
- Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stakeWhitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14
